Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
Nature Medicine2012Vol. 18(11), pp. 1688–1692
Citations Over TimeTop 1% of 2012 papers
Penny L. Moore, Elin S. Gray, Constantinos Kurt Wibmer, Jinal N. Bhiman, Molati Nonyane, Daniel J. Sheward, Tandile Hermanus, Shringkhala Bajimaya, Nancy Tumba, Melissa-Rose Abrahams, Bronwen E. Lambson, Nthabeleng Ranchobe, Li‐Hua Ping, Nobubelo Ngandu, Quarraisha Abdool Karim, Salim S. Abdool Karim, Ronald Swanstrom, Michael S. Seaman, Carolyn Williamson, Lynn Morris
Related Papers
- → Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma(2020)101 cited
- → Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma(2021)54 cited
- → Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2(2023)21 cited
- → Neutralization breadth and potency of serum derived from recently human immunodeficiency virus type 1-infected Thai individuals(2016)1 cited
- → Heterogeneity in the Properties of 7 S and 19 S Rabbit-Neutralizing Antibodies to Herpes Simplex Virus(1968)101 cited